Abstract: The present disclosure relates to a nanofiltration membrane preparation method, and a nanofiltration membrane prepared thereby. The preparation method comprises the following steps: preparing a casting solution, and curing the casting solution on a reinforcement material to form a base membrane; sequentially contacting the base membrane with a water phase solution and an oil phase solution so as to perform an interfacial polymerization reaction on the base membrane to form a polyamide functional layer, wherein the water phase solution includes a water phase monomer and an additive, the additive is a glycosylated sulfonamide compound, and the oil phase solution includes an oil phase monomer; and performing post-treatment to obtain a nanofiltration membrane, the post-treatment comprising hydroxylation treatment and crosslinking treatment.

Abstract: The present application discloses a high-toughness ultrahigh-strength steel and a manufacturing method thereof, and belongs to the technical field of metal materials. The present application is intended to solve the problem that the existing low-alloy ultrahigh-strength steel has poor toughness and poor hardenability. The high-toughness ultrahigh-strength steel includes the following elements in mass percentages: C: 0.27% to 0.35%; Si: 1.10% to 1.70%; Mn: 0.70% to 1.10%; Cr: 1.00% to 1.40%; Ni: 0.10% to 0.50%; Mo: 0.05% to 0.50%; W: 0.05% to 0.10%; Nb: 0.01% to 0.04%; and iron and unavoidable impurities: the balance. The high-toughness ultrahigh-strength steel of the present application has excellent strength, toughness and hardenability.

Abstract: Provided are a low-carbon low-alloy Q&P steel or hot-dip galvanized Q&P steel with a tensile strength greater than or equal to 1180 MPa, and a manufacturing method therefor. The steel comprises the chemical components by mass percent: C: 0.16-0.23%, Si: 1.1-2.0%, Mn: 1.6-3.0%, P?0.015%, S?0.005%, Al: 0.02-0.05%; and the steel can further comprise one or two of Cr, Mo, Ti, Nb and V, and Cr+Mo+Ti+Nb+V? 0.5%, and the balance being Fe and other unavoidable impurities. The manufacturing method comprises the processes of smelting, casting, hot rolling, cold rolling, and a rapid heat treatment or a rapid heat treatment hot dip process.

Abstract: A USB mass storage device access control method and access control apparatus, a terminal device, and a computer readable storage medium. The access control method includes: in response to detecting that a USB mass storage device is inserted into a macOS, completing matching between an application and the USB mass storage device; controlling the macOS to release an access control permission for the USB mass storage device; and controlling the application to obtain the access control permission for the USB mass storage device. The solution can solve the problem in the prior art that an application cannot be controlled to implement, on a macOS, access control over a USB mass storage device.

Abstract: Provided are a tumour antigen polypeptide having the amino acid sequence as shown in SEQ ID NO: 2 or a variant thereof; a nucleic acid encoding same; a nucleic acid construct, an expression vector, and a host cell comprising the encoding nucleic acid; and an antigen presenting cell presenting the tumour antigen polypeptide on the cell surface and an immune effector cell thereof. Also provided is the use of the polypeptide, nucleic acid, antigen presenting cell or immune effector cell in the diagnosis, prevention and treatment of cancers.

Abstract: Provided are a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid, an antigen-presenting cell presenting the polypeptide on the surface of the cell, and immune effector cell thereof, a pharmaceutical composition containing the polypeptide, a vaccine containing the nucleic acid, the nucleic acid construct, the expression vector, the host cell, the antigen-presenting cell, and the immune effector cell, and an antibody recognizing the polypeptide. Also provided is a therapeutic method using the polypeptide, the nucleic acid, the pharmaceutical composition, the vaccine, and the antibody. Also provided are a diagnosis method and diagnosis apparatus for detecting the described polypeptide. Also provided is an application of the polypeptide in preparing a vaccine, a tumor diagnosis kit, or a pharmaceutical composition, and an application of the polypeptide or the nucleic acid as a test target in tumor diagnosis.

Abstract: Provided are a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid, an antigen-presenting cell presenting the polypeptide on the surface of the cell, and immune effector cell thereof, a pharmaceutical composition containing the polypeptide, a vaccine containing the nucleic acid, the nucleic acid construct, the expression vector, the host cell, the antigen-presenting cell, and the immune effector cell, and an antibody recognizing the polypeptide. Also provided is a therapeutic method using the polypeptide, the nucleic acid, the pharmaceutical composition, the vaccine, and the antibody. Also provided are a diagnosis method and diagnosis apparatus for detecting the described polypeptide. Also provided is an application of the polypeptide in preparing a vaccine, a tumor diagnosis kit, or a pharmaceutical composition, and an application of the polypeptide or the nucleic acid as a test target in tumor diagnosis.

Abstract: A USB mass storage device access control method and access control apparatus, a terminal device, and a computer readable storage medium. Said access control method includes: in response to detecting that a USB mass storage device is inserted into a macOS, completing matching between an application and the USB mass storage device; controlling the macOS to release an access control permission for the USB mass storage device; and controlling the application to obtain the access control permission for the USB mass storage device. Said solution can solve the problem in the prior art that an application cannot be controlled to implement, on a macOS, access control over a USB mass storage device.

Abstract: A method, an apparatus, and a system for acquiring a configuration file in a data over cable service are provided. The system includes: a convergence device, a cable modem terminal system CMTS assembly, and a cable modem CM, where the convergence device is connected to the CM using the CMTS assembly. The convergence device may be configured to intercept a first DHCP response message sent by a DHCP server to the CM; acquire configuration file information of the CM from the first DHCP response message; send the configuration file information of the CM to the CMTS assembly; replace address information of a Trivial File Transfer Protocol TFTP server in the first DHCP response message with address information of the convergence device, to form a second DHCP response message; and send the second DHCP response message to the CM.

Abstract: A DPI adaptation method and an electronic device are provided. The DPI adaptation method includes: obtaining dots per inch DPI of the electronic device and DPI supported by an application, where the DPI of the electronic device includes at least one of logical DPI of the electronic device or physical DPI of the electronic device; determining a general display type of the electronic device, where the general display type is a most-used display type of the electronic device; determining target DPI according to the DPI of the electronic device, the DPI supported by the application, and the general display type; and displaying a user interface of the application by using the target DPI.

Abstract: Provided are a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid, an antigen-presenting cell presenting the polypeptide on the surface of the cell, and immune effector cell thereof, a pharmaceutical composition containing the polypeptide, a vaccine containing the nucleic acid, the nucleic acid construct, the expression vector, the host cell, the antigen-presenting cell, and the immune effector cell, and an antibody recognizing the polypeptide. Also provided is a therapeutic method using the polypeptide, the nucleic acid, the pharmaceutical composition, the vaccine, and the antibody. Also provided are a diagnosis method and diagnosis apparatus for detecting the described polypeptide. Also provided is an application of the polypeptide in preparing a vaccine, a tumor diagnosis kit, or a pharmaceutical composition, and an application of the polypeptide or the nucleic acid as a test target in tumor diagnosis.

Abstract: Provided are a polypeptide and nucleic acid for encoding the polypeptide, a nucleic-acid construct, an expression vector, and a host cell containing the nucleic acid, an antigen-presenting cell presenting the polypeptide on the surface of the cell, and immune effector cell thereof, a pharmaceutical composition containing the polypeptide, a vaccine containing the nucleic acid, the nucleic acid construct, the expression vector, the host cell, the antigen-presenting cell, and the immune effector cell, and an antibody recognizing the polypeptide. Also provided is a therapeutic method using the polypeptide, the nucleic acid, the pharmaceutical composition, the vaccine, and the antibody. Also provided are a diagnosis method and diagnosis apparatus for detecting the described polypeptide. Also provided is an application of the polypeptide in preparing a vaccine, a tumor diagnosis kit, or a pharmaceutical composition, and an application of the polypeptide or the nucleic acid as a test target in tumor diagnosis.

Abstract: Provided are a tumour antigen polypeptide having the amino acid sequence as shown in SEQ ID NO: 2 or a variant thereof; a nucleic acid encoding same; a nucleic acid construct, an expression vector, and a host cell comprising the encoding nucleic acid; and an antigen presenting cell presenting the tumour antigen polypeptide on the cell surface and an immune effector cell thereof. Also provided is the use of the polypeptide, nucleic acid, antigen presenting cell or immune effector cell in the diagnosis, prevention and treatment of cancers.

Abstract: A DPI adaptation method and an electronic device are provided. The DPI adaptation method includes: obtaining dots per inch DPI of the electronic device and DPI supported by an application, where the DPI of the electronic device includes at least one of logical DPI of the electronic device or physical DPI of the electronic device; determining a general display type of the electronic device, where the general display type is a most-used display type of the electronic device; determining target DPI according to the DPI of the electronic device, the DPI supported by the application, and the general display type; and displaying a user interface of the application by using the target DPI.

Abstract: The present invention relates to a wind-water-light-magnetism-air five-energy integrated power generation device that comprises fan blades, a power generation device and a rotary shaft and further comprises a base, guide rail posts, fan blade rails and a tower. The barrel-shaped tower is concentrically and externally sleeved with the rotary shaft and is vertically fixed at the top of the base. The fan blade rails are disposed concentrically with the rotary shaft above the base, the guide rail posts are vertically fixed around the base two ends of the elongated fan blades are respectively fixed on the corresponding positions of the upper and lower guide rails, the top of the rotary shaft protrudes from the tower, and the protruding section of the rotary shaft is fixedly connected with the fan blades through two ends of a rod-shaped tower rod.

Abstract: A method, an apparatus, and a system for acquiring a configuration file in a data over cable service are provided. The system includes: a convergence device, a cable modem terminal system CMTS assembly, and a cable modem CM, where the convergence device is connected to the CM using the CMTS assembly. The convergence device may be configured to intercept a first DHCP response message sent by a DHCP server to the CM; acquire configuration file information of the CM from the first DHCP response message; send the configuration file information of the CM to the CMTS assembly; replace address information of a Trivial File Transfer Protocol TFTP server in the first DHCP response message with address information of the convergence device, to form a second DHCP response message; and send the second DHCP response message to the CM.